Literature DB >> 3388519

Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

D Kahn1, H S Lai, H Romovacek, L Makowka, D Van Thiel, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3388519      PMCID： PMC2964144     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Thymidine kinase: an inexpensive index of liver regeneration in a large animal model.

Authors:  D Kahn; J Stadler; J Terblanche; R van Hoorn-Hickman
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

2.  Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver.

Authors:  J A McGowan; N Fausto
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857
  2 in total
  15 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  FK 506 as a growth control factor.

Authors:  A Francavilla; M Barone; T E Starzl; A Zeevi; C Scotti; G Carrieri; V Mazzaferro; J Prelich; S Todo; G Eiras
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  FK 506 modulates D-galactosamine-induced hepatitis in rats.

Authors:  H Farghali; A Gasbarrini; A B Borle; M A Nalesnik; A Francavilla; S Fagiuoli; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 5.  The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.

Authors:  A Francavilla; T E Starzl; B Carr; A Azzarone; G Carrieri; Q H Zeng; K A Porter
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Protective effect of FK 506 against hepatic ischemia in rats.

Authors:  M F Sakr; G M Zetti; H Farghali; T H Hassanein; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

8.  Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.

Authors:  A Francavilla; T E Starzl; M Barone; Q H Zeng; K A Porter; A Zeevi; P M Markus; M R van den Brink; S Todo
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

9.  Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

Authors:  A Francavilla; M Barone; S Todo; Q Zeng; K A Porter; T E Starzl
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

10.  Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.

Authors:  L Rossaro; V Mazzaferro; C L Scotti-Foglieni; D S Williams; E Simplaceanu; V Simplaceanu; A Francavilla; T E Starzl; C Ho; D H Van Thiel
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.